EssilorLuxottica reported consolidated revenue of €7,111 million ($7.75 billion) for Q2 2025, representing a year-on-year increase of 7.3% compared to Q2 2024.The adjusted EPS for the first half of 2025 was €3.04 ($3.31), a 0.7% increase from €3.02 ($3.29) in H1 2024.
The company's adjusted operating income for H1 2025 was €2.53 billion ($2.76 billion), with a stable adjusted operating margin of 18.3%. EssilorLuxottica's H1 2025 adjusted net income attributable to the group was €1.80 billion ($1.96 billion), up 6.1%. Free cash flow for H1 2025 was reported at €951 million ($1.04 billion), reflecting strong financial health despite increased capital expenditure.
EssilorLuxottica (OTC:ESLOY) is a global leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses. Formed in 2018 through the merger of Essilor and Luxottica, the company operates in over 150 countries and owns iconic brands like Ray-Ban and Oakley. It competes with eyewear companies such as Safilo Group and Marchon Eyewear.
On July 28, 2025, EssilorLuxottica announced its Q2 and H1 2025 results. During the earnings call, Chairman and CEO Francesco Milleri and Deputy CEO Paul du Saillant highlighted the company's strong performance across all regions and businesses, driven by innovations like Ray-Ban Meta (with sales up over 200% in H1), the launch of Oakley Meta Performance AI glasses, and the rollout of Nuance Audio in 10,000 stores across North America and Europe. The acquisition of Optegra clinics further supports its med-tech strategy.Despite a volatile economic environment, EssilorLuxottica's robust revenue growth and stable operating margins underscore its strong position in the global eyewear and med-tech markets. The company continues to target mid-single-digit annual revenue growth through 2026, with an anticipated adjusted operating profit margin of 19-20%
